Sanofi Myeloma (@sanofimyeloma) 's Twitter Profile
Sanofi Myeloma

@sanofimyeloma

Sanofi Myeloma is committed to helping patients with multiple myeloma, including relapsed and refractory multiple myeloma (RRMM). #MultipleMyeloma

ID: 1440302065457061890

linkhttps://www.TransformMyeloma.com/ calendar_today21-09-2021 13:10:26

3 Tweet

926 Followers

1 Following

Sanofi Myeloma (@sanofimyeloma) 's Twitter Profile Photo

#MultipleMyeloma is a critical health condition affecting patients, their caregivers and healthcare providers. We all have a part in addressing the impact of cancer. #CancerCare

Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile Photo

#Myeloma Paper of the Day: Study assessing molecular residual disease by circulating tumor DNA (ctDNA) finds 14/15 post-AHCT ctDNA-positive patients relapsed; median PFS for ctDNA-positive patients was 31 mos, 84 mos for ctDNA-negative patients: pubmed.ncbi.nlm.nih.gov/35186734/.

#Myeloma Paper of the Day: Study assessing molecular residual disease by circulating tumor DNA (ctDNA) finds 14/15 post-AHCT ctDNA-positive patients relapsed; median PFS for ctDNA-positive patients was 31 mos, 84 mos for ctDNA-negative patients: pubmed.ncbi.nlm.nih.gov/35186734/.
Sanofi (@sanofi) 's Twitter Profile Photo

With @Blackstone, we’re pleased to announce a strategic collaboration under which Blackstone Life Sciences will help accelerate the global pivotal trial and clinical development program of our medicine to help patients with #MultipleMyeloma. sanofi.com/en/media-room/…

With @Blackstone, we’re pleased to announce a strategic collaboration under which Blackstone Life Sciences will help accelerate the global pivotal trial and clinical development program of our medicine to help patients with #MultipleMyeloma. sanofi.com/en/media-room/…